首页 > 最新文献

Pleural and Mediastinal Malignancies最新文献

英文 中文
Comparing the Success Rate of Pleurodesis with Thoracoscopic Talc Poudrage Combined with Indwelling Pleural Catheter versus Thoracoscopic Talc Poudrage in Patient with Malignant Pleural Effusion, A Randomized, Non-inferiority Clinical Trial 恶性胸腔积液患者胸腔穿刺术与胸腔镜下滑石粉置入术联合留置胸膜导管与胸腔镜下滑石粉置入术成功率的比较,一项随机、非劣效临床试验
Pub Date : 2023-09-09 DOI: 10.58837/chula.the.2022.248
Jitanong Sootlek
Background: Malignant pleural effusion (MPE) can cause dyspnea symptoms that greatly impact a patient's quality of life. Talc pleurodesis or indwelling pleural catheter (IPC) insertion are two treatment options that can prevent recurrent MPE, alleviate dyspnea, and improve quality of life. However, talc pleurodesis requires a lengthy hospital stay, while IPC insertion is associated with lower pleurodesis success rates. Due to limited hospital bed capacity, we have devised a practical approach to managing MPE by combining TTP and IPC. Objective: This study aims to evaluate the efficacy of combined Thoracoscopic talc poudrage (TTP) and IPC compared to TTP alone in patients with symptomatic MPE. Methods: The study was conducted as a randomized non-inferiority trial at a single center. Patients were randomly allocated to receive either TTP and IPC or TTP alone. The study collected demographic data, hospital length of stay (LOS), symptoms, and pleurodesis success rates. The primary outcome of the study was the success rate of pleurodesis at�12 weeks post-procedure. Results: Preliminary data analysis from 26 patients with a mean age of 61 years showed that the baseline characteristics were similar between the two groups, except for the baseline mean VAS dyspnea score, which was significantly higher in the TTP+IPC group. Successful pleurodesis at 12 weeks was achieved in 88.89% of the TTP+IPC group and 64.29% of the TTP alone group, with a difference of 24.6% [95% CI, -7.83% to 57.03%]. Additionally, the TTP+IPC group showed a greater reduction in dyspnea, less pain following the procedure, and less analgesic medication use. The hospital LOS was also shorter, and the overall quality of life was significantly better. Furthermore, there was no difference in the incidence of complications between the two groups. Conclusion: Combining thoracoscopic talc pleurodesis and IPC is both effective and safe for treating symptomatic MPE patients.
背景:恶性胸腔积液(MPE)可导致呼吸困难症状,严重影响患者的生活质量。滑石粉胸膜穿刺术或置入胸膜导管(IPC)是两种治疗方法,可预防 MPE 复发、缓解呼吸困难并提高生活质量。然而,滑石粉胸膜穿刺术需要较长的住院时间,而置入 IPC 的胸膜穿刺术成功率较低。由于医院床位有限,我们设计了一种结合 TTP 和 IPC 的实用方法来治疗 MPE。 研究目的本研究旨在评估胸腔镜滑石粉置入术(TTP)和 IPC 联合术对无症状 MPE 患者的疗效。 研究方法:该研究是在一个中心进行的随机非劣效性试验。患者被随机分配接受 TTP 和 IPC 或单纯 TTP 治疗。研究收集了人口统计学数据、住院时间(LOS)、症状和胸膜腔穿刺成功率。研究的主要结果是胸膜腔穿刺术后12周时的成功率。 研究结果对26名平均年龄为61岁的患者进行的初步数据分析显示,除了基线平均VAS呼吸困难评分显著高于TTP+IPC组之外,两组患者的基线特征相似。12周时,88.89%的TTP+IPC组和64.29%的单用TTP组患者成功进行了胸膜腔穿刺,两者相差24.6% [95% CI, -7.83% to 57.03%]。此外,TTP+IPC 组呼吸困难减轻幅度更大,术后疼痛更轻,镇痛药物用量更少。住院时间也更短,整体生活质量明显提高。此外,两组的并发症发生率没有差异。 结论胸腔镜滑石粉胸膜穿刺术和 IPC 对治疗有症状的 MPE 患者既有效又安全。
{"title":"Comparing the Success Rate of Pleurodesis with Thoracoscopic Talc Poudrage Combined with Indwelling Pleural Catheter versus Thoracoscopic Talc Poudrage in Patient with Malignant Pleural Effusion, A Randomized, Non-inferiority Clinical Trial","authors":"Jitanong Sootlek","doi":"10.58837/chula.the.2022.248","DOIUrl":"https://doi.org/10.58837/chula.the.2022.248","url":null,"abstract":"Background: Malignant pleural effusion (MPE) can cause dyspnea symptoms that greatly impact a patient's quality of life. Talc pleurodesis or indwelling pleural catheter (IPC) insertion are two treatment options that can prevent recurrent MPE, alleviate dyspnea, and improve quality of life. However, talc pleurodesis requires a lengthy hospital stay, while IPC insertion is associated with lower pleurodesis success rates. Due to limited hospital bed capacity, we have devised a practical approach to managing MPE by combining TTP and IPC. Objective: This study aims to evaluate the efficacy of combined Thoracoscopic talc poudrage (TTP) and IPC compared to TTP alone in patients with symptomatic MPE. Methods: The study was conducted as a randomized non-inferiority trial at a single center. Patients were randomly allocated to receive either TTP and IPC or TTP alone. The study collected demographic data, hospital length of stay (LOS), symptoms, and pleurodesis success rates. The primary outcome of the study was the success rate of pleurodesis at�12 weeks post-procedure. Results: Preliminary data analysis from 26 patients with a mean age of 61 years showed that the baseline characteristics were similar between the two groups, except for the baseline mean VAS dyspnea score, which was significantly higher in the TTP+IPC group. Successful pleurodesis at 12 weeks was achieved in 88.89% of the TTP+IPC group and 64.29% of the TTP alone group, with a difference of 24.6% [95% CI, -7.83% to 57.03%]. Additionally, the TTP+IPC group showed a greater reduction in dyspnea, less pain following the procedure, and less analgesic medication use. The hospital LOS was also shorter, and the overall quality of life was significantly better. Furthermore, there was no difference in the incidence of complications between the two groups. Conclusion: Combining thoracoscopic talc pleurodesis and IPC is both effective and safe for treating symptomatic MPE patients.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139341458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient derived malignant pleural effusion cell cultures as a platform to understand pleural malignancies and advance personalised treatment 患者来源的恶性胸腔积液细胞培养作为了解胸腔恶性肿瘤和推进个体化治疗的平台
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.16
Yu Zhao, D. Dominey-Foy, N. Kanellakis, Megat Bin Abd Hamid, X. Yao, Yanchun Peng, T. Dong, N. Rahman
{"title":"Patient derived malignant pleural effusion cell cultures as a platform to understand pleural malignancies and advance personalised treatment","authors":"Yu Zhao, D. Dominey-Foy, N. Kanellakis, Megat Bin Abd Hamid, X. Yao, Yanchun Peng, T. Dong, N. Rahman","doi":"10.1183/23120541.lsc-2022.16","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.16","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76068164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary cilium regulates cell migration and mechanical contraction in mesothelioma cell models 原发性纤毛调节间皮瘤细胞模型的细胞迁移和机械收缩
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3103
O. Kotsiou, R. Jagirdar, E. Rouka, E. Pitaraki, K. Gourgoulianis, S. Zarogiannis
{"title":"Primary cilium regulates cell migration and mechanical contraction in mesothelioma cell models","authors":"O. Kotsiou, R. Jagirdar, E. Rouka, E. Pitaraki, K. Gourgoulianis, S. Zarogiannis","doi":"10.1183/13993003.congress-2021.pa3103","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3103","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79306782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The atypical cells in the pleural effusion smears stained with May Grunwald Giemsa - is it a new possible tool not to overlook malignancy? May Grunwald Giemsa染色胸膜积液中的非典型细胞-这是一种不忽视恶性肿瘤的新可能工具吗?
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3105
E. Grabczak, P. Korczyński, A. Wiśniewska, M. Mierzejewski, Malwina Sołtysiak, Łukasz Koperski, R. Krenke
{"title":"The atypical cells in the pleural effusion smears stained with May Grunwald Giemsa - is it a new possible tool not to overlook malignancy?","authors":"E. Grabczak, P. Korczyński, A. Wiśniewska, M. Mierzejewski, Malwina Sołtysiak, Łukasz Koperski, R. Krenke","doi":"10.1183/13993003.congress-2021.pa3105","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3105","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82282451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study 一种新的蛋白质组学技术鉴定恶性胸膜间皮瘤的新诊断生物标志物:可行性研究
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1517
E. Schillebeeckx, E. Fernandez, J. V. van Meerbeeck, K. Gevaert, K. Lamote
{"title":"A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study","authors":"E. Schillebeeckx, E. Fernandez, J. V. van Meerbeeck, K. Gevaert, K. Lamote","doi":"10.1183/13993003.congress-2021.oa1517","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.oa1517","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84675071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How successful are medical thoracoscopists at predicting non-expandable lung? 医学胸腔镜医师在预测非扩张性肺方面有多成功?
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3098
Syed Ajmal, S. Johnstone, M. Tufail, R. Panchal
{"title":"How successful are medical thoracoscopists at predicting non-expandable lung?","authors":"Syed Ajmal, S. Johnstone, M. Tufail, R. Panchal","doi":"10.1183/13993003.congress-2021.pa3098","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3098","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86077907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are people with mesothelioma well represented in the English cancer patient experience survey? 间皮瘤患者在英国癌症患者经历调查中是否有很好的代表性?
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3099
Y. Nartey, I. Stewart, A. Khakwani, V. Beattie, A. Wilcock, I. Woolhouse, P. Beckett, Richard Hubbard, L. Tata
{"title":"Are people with mesothelioma well represented in the English cancer patient experience survey?","authors":"Y. Nartey, I. Stewart, A. Khakwani, V. Beattie, A. Wilcock, I. Woolhouse, P. Beckett, Richard Hubbard, L. Tata","doi":"10.1183/13993003.congress-2021.pa3099","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3099","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89257726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling 基于顶空挥发谱的间皮瘤和肺癌的体外鉴别
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1515
E. Janssens, Zoë Mol, L. Vandermeersch, C. Walgraeve, J. V. van Meerbeeck, E. Marcq, K. Lamote
{"title":"In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling","authors":"E. Janssens, Zoë Mol, L. Vandermeersch, C. Walgraeve, J. V. van Meerbeeck, E. Marcq, K. Lamote","doi":"10.1183/13993003.congress-2021.oa1515","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.oa1515","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90700187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion 单核细胞趋化蛋白-1 (MCP-1)在恶性胸腔积液发展中的作用
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1518
F. Tekin, D. Koksal, Z. Dikmen, S. Karahan, R. Bayler, Burcu Ancın, E. Dikmen, D. Akıncı, S. Onder
{"title":"The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion","authors":"F. Tekin, D. Koksal, Z. Dikmen, S. Karahan, R. Bayler, Burcu Ancın, E. Dikmen, D. Akıncı, S. Onder","doi":"10.1183/13993003.congress-2021.oa1518","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.oa1518","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83479910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary cilium modulates mesothelioma cell viability and 3D sphere formation 初生纤毛调节间皮瘤细胞活力和三维球体形成
Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1521
O. Kotsiou, R. Jagirdar, E. Rouka, E. Pitaraki, K. Gourgoulianis, S. Zarogiannis
{"title":"Primary cilium modulates mesothelioma cell viability and 3D sphere formation","authors":"O. Kotsiou, R. Jagirdar, E. Rouka, E. Pitaraki, K. Gourgoulianis, S. Zarogiannis","doi":"10.1183/13993003.congress-2021.oa1521","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.oa1521","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73058797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pleural and Mediastinal Malignancies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1